S. Sharma

发表

Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells

Li Zhu, M. Stolina, S. Dubinett, 1997, Gene Therapy.

Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways.

S. Dubinett, K. Komanduri, S. Sharma, 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors.

E. Raymond, D. V. Von Hoff, R. Schaub, 1999, Anti-cancer drugs.

Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

Li Zhu, M. Stolina, H. Herschman, 1998, Cancer research.

A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay

E. Raymond, G. Mangold, E. Izbicka, 1999, British Journal of Cancer.

Antiproliferatiye effects of recombinant human bone morphogenetic protein‐2 on human tumor colony‐forming units

Cesario Z. Cerna, E. Raymond, D. V. Von Hoff, 1998, Anti-cancer drugs.

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells

S. Gupta, R. Soldi, S. Sharma, 2016, Prostate Cancer and Prostatic Diseases.

Reversible lysine-speci fi c demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration-and docetaxel-resistant prostate cancer cells

S. Gupta, R. Soldi, S. Sharma, 2016 .

Gene therapy for lung cancer.

S. Dubinett, R. Batra, S. Sharma, 1998, Hematology/oncology clinics of North America.

Telomerase and telomere inhibitors in preclinical development.

E. Raymond, D. V. Von Hoff, S. Sharma, 1997, Expert opinion on investigational drugs.

Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.

S. Dubinett, S. Sharma, M. Huang, 1996, Journal of immunology.

T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.

M. Stolina, M. Kronenberg, S. Dubinett, 1999, Journal of immunology.

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.

L. Butterfield, M. Stolina, M. Dohadwala, 2000, Human gene therapy.

Preclinical and clinical strategies for development of telomerase and telomere inhibitors.

E. Raymond, D. V. Von Hoff, S. Hilsenbeck, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.

R. Strieter, M. Stolina, R. Batra, 2001, Cancer research.

Dependence of mutation induction on fast-neutron energy in a human epithelial teratocarcinoma cell line (P3).

C. Hill, S. Sharma, S. Sharma, 1996, Radiation research.

Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line.

E. Raymond, D. V. Von Hoff, E. Izbicka, 1998, Leukemia research.

Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta.

Li Zhu, S. Dubinett, D. Tashkin, 1997, Cellular immunology.

Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.

M. Stolina, S. Sharma, P. Miller, 1998, Cancer gene therapy.